First ‘gene silencing’ drug for Alzheimer’s disease shows promise

24 April 2023

A world-first trial at UCL and UCLH led by Dr Catherine Mummery (UCL Queen Square Institute of Neurology) has found a new genetic therapy for Alzheimer’s disease that is able to safely and successfully lower levels of the harmful tau protein known to cause the disease.